Madam Therapeutics

SAAP-148 is active against a broad spectrum of gram-negative and gram-positive bacteria

Antimicrobial peptides (AMPs), such as SAAP-148 that is developed by Madam Therapeutics, are among the more exiting developments in today’s anti-microbial development space.

SAAP-148 has shown the ability to kill a broad spectrum of gram-negative and gram-positive bacteria, enveloped viruses, fungi and even cancerous cells. Moreover SAAP-148 offers the prospect of enhancing immunity by functioning as immunomodulator.